In his research, Nigel H. Russell undertakes multidisciplinary study on Biochemistry and Biophysics. His work often combines Biophysics and Biochemistry studies. His work on Candida albicans expands to the thematically related Microbiology. His Microbiology research extends to the thematically linked field of Candida albicans. His work on Membrane is being expanded to include thematically relevant topics such as Lysophosphatidylcholine. His Lysophosphatidylcholine study frequently links to related topics such as Membrane. He undertakes interdisciplinary study in the fields of Bacteria and Food poisoning through his works. Nigel H. Russell merges many fields, such as Food poisoning and Salmonella, in his writings. He performs multidisciplinary study on Salmonella and Listeria monocytogenes in his works.
Nigel H. Russell performs integrative study on Biochemistry and Chromatography. Bacteria and Enzyme are two areas of study in which Nigel H. Russell engages in interdisciplinary work. Nigel H. Russell combines Enzyme and Bacteria in his studies. In his works, he performs multidisciplinary study on Genetics and Microbiology. In his research, he performs multidisciplinary study on Microbiology and Genetics. Nigel H. Russell performs integrative study on Organic chemistry and Biochemistry. His Membrane study typically links adjacent topics like Phosphatidylglycerol. He carries out multidisciplinary research, doing studies in Phosphatidylglycerol and Phosphatidylcholine. Phosphatidylcholine and Phospholipid are two areas of study in which he engages in interdisciplinary research.
Nigel H. Russell regularly ties together related areas like Lethargy in his Internal medicine studies. His research is interdisciplinary, bridging the disciplines of Internal medicine and Lethargy. His Nemaline myopathy study frequently draws parallels with other fields, such as Pathology. Many of his studies on Pathology involve topics that are commonly interrelated, such as Myopathy. In his work, he performs multidisciplinary research in Myopathy and Nemaline myopathy. Many of his studies involve connections with topics such as Myocarditis and Cardiology. Myocarditis and Cardiology are commonly linked in his work. He conducts interdisciplinary study in the fields of Quaternary and Paleontology through his works. Nigel H. Russell combines Paleontology and Quaternary in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman.
Assessment of Minimal Residual Disease in Standard-Risk AML.
Adam Ivey;Robert Kerrin Hills;Michael A. Simpson;Jelena V. Jovanovic.
The New England Journal of Medicine (2016)
Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen.
Journal of Clinical Oncology (2011)
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)
Norbert Schmitz;Peter Dreger;Meinolf Suttorp;Ernst B. Rohwedder.
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
Stephen P. Robinson;Anthony H. Goldstone;Stephen Mackinnon;Angelo Carella.
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison.
Journal of Clinical Oncology (2015)
Targeting FLT3 mutations in AML: review of current knowledge and evidence.
Naval Daver;Richard F. Schlenk;Nigel H. Russell;Mark J. Levis.
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
G. Gahrton;H. Svensson;M. Cavo;J. Apperley.
British Journal of Haematology (2001)
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.
Gareth J. Morgan;Walter M. Gregory;Faith E. Davies;Sue E. Bell.
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Alan K Burnett;Nigel H Russell;Robert Kerrin Hills;David Bowen.
Lancet Oncology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: